PH26214A - Pharmaceutical formulation for the treatment of bacterial infections - Google Patents

Pharmaceutical formulation for the treatment of bacterial infections Download PDF

Info

Publication number
PH26214A
PH26214A PH35336A PH35336A PH26214A PH 26214 A PH26214 A PH 26214A PH 35336 A PH35336 A PH 35336A PH 35336 A PH35336 A PH 35336A PH 26214 A PH26214 A PH 26214A
Authority
PH
Philippines
Prior art keywords
coli
fic
strain
citrobacter freundii
values
Prior art date
Application number
PH35336A
Other languages
English (en)
Inventor
Michael Limbert
Elmer Schrinner
Gerhard Seibert
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of PH26214A publication Critical patent/PH26214A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Cephalosporin Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
PH35336A 1986-06-04 1987-06-02 Pharmaceutical formulation for the treatment of bacterial infections PH26214A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19863618813 DE3618813A1 (de) 1986-06-04 1986-06-04 Pharmazeutische zubereitung zur behandlung bakterieller infektionen

Publications (1)

Publication Number Publication Date
PH26214A true PH26214A (en) 1992-03-18

Family

ID=6302277

Family Applications (1)

Application Number Title Priority Date Filing Date
PH35336A PH26214A (en) 1986-06-04 1987-06-02 Pharmaceutical formulation for the treatment of bacterial infections

Country Status (27)

Country Link
US (1) US4919932A (instruction)
EP (1) EP0248361B1 (instruction)
JP (1) JPS62292721A (instruction)
CN (1) CN87104023A (instruction)
AR (1) AR241305A1 (instruction)
AT (1) ATE71299T1 (instruction)
AU (1) AU597068B2 (instruction)
CA (1) CA1294217C (instruction)
DD (1) DD257015A5 (instruction)
DE (2) DE3618813A1 (instruction)
DK (1) DK166759B1 (instruction)
EG (1) EG18213A (instruction)
ES (1) ES2035829T3 (instruction)
FI (1) FI872459A7 (instruction)
GR (1) GR3003856T3 (instruction)
HU (1) HU199288B (instruction)
IL (1) IL82767A (instruction)
MA (1) MA20994A1 (instruction)
MY (1) MY101079A (instruction)
NO (1) NO872331L (instruction)
NZ (1) NZ220509A (instruction)
OA (1) OA08609A (instruction)
PH (1) PH26214A (instruction)
PL (1) PL266058A1 (instruction)
PT (1) PT84996B (instruction)
TN (1) TNSN87077A1 (instruction)
ZA (1) ZA873970B (instruction)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1231487B (it) * 1988-10-24 1991-12-07 Erba Carlo Spa Composizione sinergica antibatterica contenente penem e ceftizoximaf
DE69019395D1 (de) * 1989-02-21 1995-06-22 Banyu Pharma Co Ltd Zusammensetzung gegen Mikroben.
DE3909056A1 (de) * 1989-03-18 1990-09-20 Hoechst Ag Pharmazeutische kombinationspraeparate und deren verwendung zur prophylaxe oder behandlung bakterieller infektionskrankheiten
ZA944369B (en) * 1993-08-27 1995-02-13 Hokuriku Seuyaku Co Ltd 5-amino-8-methyl-7-pyrrolidinylquinoline-3-carboxylic acid derivative
US7491263B2 (en) * 2004-04-05 2009-02-17 Technology Innovation, Llc Storage assembly

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS54126735A (en) * 1978-03-24 1979-10-02 Toyama Chem Co Ltd Bactericidal composition for medical use
DE3176517D1 (en) * 1980-04-24 1987-12-17 Beecham Group Plc Beta-lactam compounds, their preparation and use
ES8305366A1 (es) * 1981-07-08 1983-04-01 Hoechst Uk Ltd "procedimiento para la preparacion de derivados de penem".
EP0120613A1 (en) * 1983-03-02 1984-10-03 Beecham Group Plc Penem derivatives and precursors
DE3424144A1 (de) * 1984-06-30 1986-01-09 Bayer Ag, 5090 Leverkusen Verfahren zur erhoehung der bruchfestigkeit von granalien

Also Published As

Publication number Publication date
OA08609A (fr) 1988-11-30
MA20994A1 (fr) 1987-12-31
PT84996A (de) 1987-07-01
AR241305A1 (es) 1992-05-29
FI872459L (fi) 1987-12-05
NO872331D0 (no) 1987-06-03
MY101079A (en) 1991-07-16
TNSN87077A1 (fr) 1990-01-01
DK284787D0 (da) 1987-06-03
NO872331L (no) 1987-12-07
DD257015A5 (de) 1988-06-01
IL82767A (en) 1992-09-06
AU597068B2 (en) 1990-05-24
IL82767A0 (en) 1987-12-20
ES2035829T3 (es) 1993-05-01
DK284787A (da) 1987-12-05
FI872459A7 (fi) 1987-12-05
ZA873970B (en) 1987-12-02
FI872459A0 (fi) 1987-06-02
HU199288B (en) 1990-02-28
EP0248361A2 (de) 1987-12-09
ATE71299T1 (de) 1992-01-15
CA1294217C (en) 1992-01-14
EP0248361A3 (en) 1989-09-06
DK166759B1 (da) 1993-07-12
US4919932A (en) 1990-04-24
DE3775823D1 (de) 1992-02-20
JPS62292721A (ja) 1987-12-19
GR3003856T3 (instruction) 1993-03-16
NZ220509A (en) 1989-11-28
EP0248361B1 (de) 1992-01-08
PT84996B (pt) 1990-03-08
HUT44926A (en) 1988-05-30
PL266058A1 (en) 1988-07-21
AU7379587A (en) 1987-12-10
DE3618813A1 (de) 1987-12-10
EG18213A (en) 1992-09-30
CN87104023A (zh) 1988-03-09

Similar Documents

Publication Publication Date Title
O'callaghan et al. GR 20263, a new broad-spectrum cephalosporin with anti-pseudomonal activity
Brumfitt et al. Cefoxitin and cephalothin: antimicrobial activity, human pharmacokinetics, and toxicology
Fu et al. Piperacillin, a new penicillin active against many bacteria resistant to other penicillins
Georgopapadakou et al. Binding of beta-lactam antibiotics to penicillin-binding proteins of Staphylococcus aureus and Streptococcus faecalis: relation to antibacterial activity
Pruul et al. Potentiation of antibacterial activity of azithromycin and other macrolides by normal human serum
Chin et al. Synergy of ciprofloxacin and azlocillin in vitro and in a neutropenic mouse model of infection
Miller et al. Cephamycins, a new family of β-lactam antibiotics. III. In vitro studies
Norrby et al. Comparative in vitro activity of PD 127,391, a new fluorinated 4-quinolone derivative
PH26214A (en) Pharmaceutical formulation for the treatment of bacterial infections
Meyers et al. Antibacterial Activity of Cefamandole III Vitro
Winston et al. Controlled trials of double beta-lactam therapy with cefoperazone plus piperacillin in febrile granulocytopenic patients
Daschner et al. Pharmacokinetics of vancomycin in serum and tissue of patients undergoing open-heart surgery
Neu Ceftizoxime: A beta‐lactamase‐stable, broad‐spectrum cephalosporin
Yogev et al. Intraventricular levels of amikacin after intravenous administration
English et al. Laboratory evaluation of 3-(5-tetrazolyl) penam, a new semisynthetic beta-lactam antibacterial agent with extended broad-spectrum activity
Steele et al. Ceftriaxone for the treatment of serious infections
Hyslop et al. Loracarbef (LY163892) versus cefaclor and norfloxacin in the treatment of uncomplicated pyelonephritis
Moore et al. 6 beta-Iodopenicillanic acid (UI-38,006), a beta-lactamase inhibitor that extends the antibacterial spectrum of beta-lactam compounds: initial bacteriological characterization
Shadomy et al. In vitro activity of five oral cephalosporins against anaerobic pathogenic bacteria
Wise Comparative microbiological activity and pharmacokinetics of cefprozil
Sheppard et al. In vitro activity of cefpodoxime, a new oral cephalosporin, compared with that of nine other antimicrobial agents
Randolph et al. Comparative bactericidal effect of ceforanide (BL-S 786) and five other cephalosporins in an in vitro pharmacokinetic model
Lode et al. Prospective randomized clinical trials of new quinolones versus b-lactam antibiotics in lower respiratory tract infections
Ribner et al. Treatment of serious infections with moxalactam
Webber et al. Moxalactam: The first of a new class of β-lactam antibiotics